MedTrace Logo

A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness

NCT06779981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2025-06-25

No results posted yet for this study

Summary

This prospective epidemiological cohort study is being conducted in order to generate epidemiological data in support of Osivax's clinical development of a broad-spectrum influenza vaccine based upon the internal influenza nucleoprotein (NP), i.e., OVX836.

Conditions

Interventions

OTHER

Nasopharyngeal swabs

Completion of an electronic Diary (eDiary) and collection of nasopharyngeal swabs in case the subject experiences ILI symptoms

Sponsors & Collaborators

  • Harmony Clinical Research BVBA

    collaborator OTHER

  • Inferential

    collaborator INDUSTRY

  • University Hospital, Ghent

    collaborator OTHER

  • Osivax

    lead INDUSTRY

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-13
Primary Completion
2025-06-19
Completion
2025-06-19

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06779981 on ClinicalTrials.gov